Managing Heart Valve Problems During Aortic Valve Replacement
Part of Heart & circulation clinical trials.
This trial tests a treatment plan for patients getting a new aortic valve (through a catheter) who also have leaking mitral or tricuspid valves. The goal is to find the best way to manage these multiple valve problems together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe aortic stenosis (a narrowed aortic valve) and need a TAVI procedure (a catheter-based valve replacement)
- You have moderate-to-severe leaking in your mitral valve (the valve between your heart's upper and lower left chambers) and/or tricuspid valve (the valve between your heart's upper and lower right chambers)
- Your life expectancy is at least 1 year
- You have never had prior surgery on your mitral or tricuspid valves
- You do not have an active heart infection, blood clots, or growths inside your heart
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two types of replacement heart valves (self-expanding and balloon-expanding) in people who have severe aortic stenosis (tight heart valve) and an enlarged aorta (the main blood vessel from the heart). The goal is to see which valve type works better for these patients.
This study tracks how well new heart valve replacement and repair devices work after they're implanted. Researchers will monitor your health over time to ensure the device is safe and functioning properly.
This study looks at whether people with both severe aortic valve narrowing and cardiac amyloidosis (a buildup of abnormal proteins in the heart) can benefit from a valve replacement procedure. It may help doctors understand how common this combination is and how to improve care.
This study tests a catheter-based procedure to replace a narrowed aortic valve without traditional open-heart surgery. It's designed for patients who are at higher risk for surgery due to age, health conditions, or anatomy.
This trial tests a minimally invasive procedure called TAVI (transcatheter aortic valve implantation) to replace a narrowed aortic valve without requiring open-heart surgery. The study is checking whether TAVI can be safely performed at hospitals that don't have cardiac surgery units on-site.
This trial tests if a heart valve replacement procedure called TAVI can be safely done at heart centers that do not have a full heart surgery team available onsite. It is for people with severe narrowing of the aortic valve who are already planned for TAVI through the leg artery.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.